Uroš Pecikoza, PhD

Др сц. Мирослав Савић

Position: Assistant Professor
Organizational unit: Department of Pharmacology
Room: B105
Phone: +381 11 3951-274
Fax: +381 11 3972-840
Emailupecikoza@pharmacy.bg.ac.rs

CV


Uroš Pecikoza was born in 1987 in Belgrade. He has finished integrated academic studies (major: Master of Pharmacy) at the Faculty of Pharmacy in Belgrade in 2011. He completed his doctoral academic studies (module: Pharmacology) at the same faculty in 2021.

Since 2013, he has been employed at the Department of Pharmacology of the Faculty of Pharmacy in Belgrade (firstly as a teaching associate, then since 2016 as a teaching assistant and since 2021 as a teaching assistant with PhD). He participates in the planning and implementation of compulsory and elective courses organized by the Department of Pharmacology within the integrated academic studies. In addition, he participates in the planning and implementation of practical classes in specialist academic studies in Pharmacotherapy in pharmaceutical practice. He is the co-author of two chapters in the textbook Pharmacotherapy for Pharmacists (2nd edition).

The field of scientific research work of Uroš Pecikoza is the pharmacology of pain. He has published 14 papers in international journals and one chapter in a monograph of international importance. He is a member of the Serbian Pharmacological Society, Society for Neuroscience of Serbia and International Association for the Study of Pain (IASP). In the period from 2012 to 2020, he was engaged as a researcher on the scientific project of basic research of the Ministry of Education, Science and Technological Development of the Republic of Serbia (No. 175045). Since 2022, he has been engaged as a researcher on a project within The Program IDEAS (funded by the Science Fund of the Republic of Serbia).

 
  • Djekic L, Marković B, Micov A, Tomić M, Pecikoza U, Stepanović-Petrović R. Percutaneous delivery of levetiracetam as an alternative to topical nonsteroidal anti-inflammatory drugs: formulation development, in vitro and in vivo characterization. Drug Deliv Transl Res. 2021;11(1):227-41.
  • Tomić M, Pecikoza U, Micov A, Vučković S, Stepanović-Petrović R. Antiepileptic drugs as analgesics/adjuvants in inflammatory pain: current preclinical evidence. Pharmacol Ther. 2018;192:42-64.
  • Micov AM, Tomić MA, Todorović MB, Vuković MJ, Pecikoza UB, Jasnic NI, Djordjevic JD, Stepanović-Petrović RM. Vortioxetine reduces pain hypersensitivity and associated depression-like behavior in mice with oxaliplatin-induced neuropathy. Prog Neuropsychopharmacol Biol Psychiatry. 2020;103:109975.
  • Pecikoza U, Tomić M, Micov A, Vuković M, Stepanović-Petrović R. Eslicarbazepine acetate interacts in a beneficial manner with standard and alternative analgesics to reduce trigeminal nociception. Psychopharmacology (Berl). 2020;237(5):1435-46.
  • Pecikoza U, Micov A, Tomić M, Stepanović-Petrović R. Eslicarbazepine acetate reduces trigeminal nociception: Possible role of adrenergic, cholinergic and opioid receptors. Life Sci. 2018;214:167-75.
  • Dinić M, Pecikoza U, Djokić J, Stepanović-Petrović R, Milenković M, Stevanović M, Filipović N, Begović J, Golić N, Lukić J. Exopolysaccharide Produced by Probiotic Strain Lactobacillus paraplantarum BGCG11 Reduces Inflammatory Hyperalgesia in Rats. Front Pharmacol. 2018;9:1.
  • Pecikoza UB, Tomić MA, Micov AM, Stepanović-Petrović RM. Metformin Synergizes With Conventional and Adjuvant Analgesic Drugs to Reduce Inflammatory Hyperalgesia in Rats. Anesth Analg. 2017;124(4):1317-29.
  • Micov A, Tomić M, Pecikoza U, Ugrešić N, Stepanović-Petrović R. Levetiracetam synergises with common analgesics in producing antinociception in a mouse model of painful diabetic neuropathy. Pharmacol Res. 2015;97:131-42.
  • Samardžić S, Tomić M, Pecikoza U, Stepanović-Petrović R, Maksimović Z. Antihyperalgesic activity of Filipendula ulmaria (L.) Maxim. and Filipendula vulgaris Moench in a rat model of inflammation. J Ethnopharmacol. 2016;193:652-56.
  • Tomić MA, Pecikoza UB, Micov AM, Stepanović-Petrović RM. The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors. Anesth Analg. 2015;121(6):1632-9.